Elevated regional cerebral blood flow in adults with 22q11.2 deletion syndrome-Reference-Cited by-同舟云学术

Elevated regional cerebral blood flow in adults with 22q11.2 deletion syndrome

Published:2022-07-15 Issue:3 Volume:24 Page:260-265
ISSN:1562-2975
Container-title:The World Journal of Biological Psychiatry
language:en
Short-container-title:The World Journal of Biological Psychiatry

Author:

Pasternak Maurice¹^ORCID,Shirzadi Zahra²^ORCID,Mutsaerts Henk J. M. M.³^ORCID,Boot Erik⁴⁵⁶^ORCID,Butcher Nancy J.⁷⁸^ORCID,MacIntosh Bradley J.⁹¹⁰^ORCID,Heung Tracy⁶¹¹¹²,Bassett Anne S.⁶⁷¹¹¹²^ORCID,Masellis Mario¹⁹¹³¹⁴^ORCID

Affiliation:

1. Institute of Medical Science, University of Toronto, Toronto, Canada

2. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, MA, USA

3. Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, the Netherlands

4. Department of Psychiatry & Neuropsychology, Maastricht University, The Netherlands

5. Advisium’s Heeren Loo Zorggroep, Amersfoort, The Netherlands

6. Dalglish Family 22q Clinic, Toronto General Hospital, and Toronto General Hospital Research Institute, University Health Network, Toronto, Canada

7. Department of Psychiatry, University of Toronto, Toronto, Canada

8. Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Canada

9. Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Canada

10. Department of Medical Biophysics, University of Toronto, Toronto, Canada

11. Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Canada

12. Campbell Family Research Institute Toronto, Toronto, Canada

13. Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada

14. L.C. Campbell Cognitive Neurology Research Unit, Sunnybrook Health Sciences Centre, Toronto, Canada

Funder

Canadian Institutes of Health Research

the Canada Research Chairs Program

a Brain Canada Mental Health Training Award

Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship

School of Graduate Studies University-Wide Award scholarship funding from the Institute of Medical Science, University of Toronto

Dalglish Family Chair in 22q11.2 Deletion Syndrome at the University Health Network and University of Toronto

the Dutch Heart Foundation

European Union Horizon

research and innovation program

Netherlands Enterprise Agency (RvO),

EU Joint Program for Neurodegenerative Disease Research

Organisation for health Research and Development and Alzheimer Nederland

Ontario Brain Institute, the Canadian Institutes of Health Research, Woman’s Brain Health Initiative, Brain Canada, Weston Brain Institute and Washington University

Scientific Advisory Committee for Ionis Pharmaceuticals, Alector Pharmaceuticals, Wave Life Sciences, and Biogen Canada

Henry Stewart Talks

Roche, and Alector Pharmaceuticals

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

https://www.tandfonline.com/doi/pdf/10.1080/15622975.2022.2093969

Reference15 articles.

1. Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second Cohort

3. 22q11 deletion syndrome: a genetic subtype of schizophrenia

4. Estimate of the contemporary live-birth prevalence of recurrent 22q11.2 deletions: a cross-sectional analysis from population-based newborn screening

5. Neuroradiographic findings in 22q11.2 deletion syndrome